ConvaTec ( (GB:CTEC) ) has provided an announcement.
Convatec Group Plc announced the grant of conditional awards to its CEO, Karim Bitar, and CFO, Jonny Mason, under the company’s Long Term Incentive Plan (LTIP) and Deferred Bonus Plan (DBP). These awards, in the form of Performance Share Awards and Restricted Stock Units, are set to vest in three years, with the LTIP awards contingent on specific performance conditions. This move underscores Convatec’s commitment to aligning executive incentives with company performance, potentially impacting its market positioning and stakeholder interests.
More about ConvaTec
Convatec is a global medical products and technologies company specializing in solutions for managing chronic conditions. It holds leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. With over 10,000 employees, Convatec operates in approximately 90 countries, offering products that enhance patient outcomes and reduce care costs. The company reported revenues exceeding $2 billion in 2024 and is part of the FTSE 100 Index.
YTD Price Performance: 19.35%
Average Trading Volume: 5,659,776
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: £5.41B
For detailed information about CTEC stock, go to TipRanks’ Stock Analysis page.